# Single Dose Bronchodilatory Study in Asthma

> **NCT01805687** · PHASE4 · COMPLETED · sponsor: **Cornerstone Therapeutics Inc.** · enrollment: 25 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Zileuton extended release

## Key facts

- **NCT ID:** NCT01805687
- **Lead sponsor:** Cornerstone Therapeutics Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-03
- **Primary completion:** 2013-06
- **Final completion:** —
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2014-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01805687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01805687, "Single Dose Bronchodilatory Study in Asthma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01805687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*